Paper38400007
Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1.
Liu B and 5 others. Viruses, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1. Papers, record 38400007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38400007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Varicellovirus | Major topic |
| Herpesviridae Infections | Major topic |
| Oleanolic Acid | Major topic |
| Saponins | Major topic |
| Hydrolyzable Tannins | Major topic |
| Animals | |
| Cats | |
| Humans | |
| Antiviral Agents |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 660/2416032 | Qingdao Agricultural University | PubMed | ||
| WST2019013 | Department of Science & Technology of Shandong Province | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32827314 | Punicalagin is a neuraminidase inhibitor of influenza viruses. | J Med Virol | 2021 | https://conductscience.org/library/papers/32827314 | PubMed |
| 2 | 36735616 | Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs. | Nucleic Acid Ther | 2023 | https://conductscience.org/library/papers/36735616 | PubMed |
| 3 | 16640781 | In vitro comparison of antiviral drugs against feline herpesvirus 1. | BMC Vet Res | 2006 | https://conductscience.org/library/papers/16640781 | PubMed |
| 4 | 25450204 | Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. | J Hepatol | 2015 | https://conductscience.org/library/papers/25450204 | PubMed |
| 5 | 21078929 | Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21078929 | PubMed |
| 6 | 9573262 | Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. | J Virol | 1998 | https://conductscience.org/library/papers/9573262 | PubMed |
| 7 | 27591143 | Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA. | Antiviral Res | 2016 | https://conductscience.org/library/papers/27591143 | PubMed |
| 8 | 37493545 | Feline herpesvirus 1 (FHV-1) enters the cell by receptor-mediated endocytosis. | J Virol | 2023 | https://conductscience.org/library/papers/37493545 | PubMed |
| 9 | 31246133 | Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease. | J Feline Med Surg | 2020 | https://conductscience.org/library/papers/31246133 | PubMed |
| 10 | 25865056 | Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. | Antiviral Res | 2015 | https://conductscience.org/library/papers/25865056 | PubMed |
| 11 | 14531019 | Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. | Planta Med | 2003 | https://conductscience.org/library/papers/14531019 | PubMed |
| 12 | 31013527 | [Treatment of acute viral feline upper respiratory tract infections]. | Tierarztl Prax Ausg K Kleintiere Heimtiere | 2019 | https://conductscience.org/library/papers/31013527 | PubMed |
| 13 | 32183205 | Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes with Viral Replication. | Microorganisms | 2020 | https://conductscience.org/library/papers/32183205 | PubMed |
| 14 | 17296160 | Feline herpesvirus. | Vet Res | 2007 | https://conductscience.org/library/papers/17296160 | PubMed |
| 15 | 24112415 | In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites. | Vet Ophthalmol | 2014 | https://conductscience.org/library/papers/24112415 | PubMed |
| 16 | 23830812 | Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo. | Chem Biol Interact | 2013 | https://conductscience.org/library/papers/23830812 | PubMed |
| 17 | 23946457 | Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins. | J Virol | 2013 | https://conductscience.org/library/papers/23946457 | PubMed |
| 18 | 15077679 | In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. | Am J Vet Res | 2004 | https://conductscience.org/library/papers/15077679 | PubMed |
| 19 | 36261852 | Evaluation of compounded cidofovir, famciclovir, and ganciclovir for the treatment of feline herpesvirus ocular surface disease in shelter-housed cats. | Vet Ophthalmol | 2023 | https://conductscience.org/library/papers/36261852 | PubMed |
| 20 | 9764399 | Properties and functions of feline herpesvirus type 1 glycoproteins. | J Vet Med Sci | 1998 | https://conductscience.org/library/papers/9764399 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797828 | In Vitro Assessment of Antiviral Activity of Saikosaponin B2 Against Porcine Epidemic Diarrheal Virus. | Viruses | 2026 | https://conductscience.org/library/papers/42797828 | PubMed |
| 42790425 | Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42790425 | PubMed |
| 40927696 | Antibacterial and antiviral properties of punicalagin (Review). | Med Int (Lond) | 2025 | https://conductscience.org/library/papers/40927696 | PubMed |
| 40284727 | Preliminary Data on the Antiviral Activity of Helleborus bocconei subsp. intermedius Root Extracts Against Animal Herpesviruses. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284727 | PubMed |
| 40005840 | The Therapeutic Efficacy and Molecular Mechanisms of Artemisia argyi Essential Oil in Treating Feline Herpesvirus Infection via Nasal Drops. | Vet Sci | 2025 | https://conductscience.org/library/papers/40005840 | PubMed |
| 39858850 | Alphaherpesvirus in Pets and Livestock. | Microorganisms | 2025 | https://conductscience.org/library/papers/39858850 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38400007
GET https://conductscience.org/api/papers/v1/38400007/references?page=2